Get a Grip on Non-Medicare Costs By Porter Leslie Many claimants are asked to make decisions on the non-Medicare covered portion of settlements with little information on future costs.
Physician Dispensing Skirts Controls By Ramona Tanabe Skirting the goals of state reforms, physician dispensing is increasing for new formulations of drugs that carry higher prices.
A New Dimension in Population Health By Munzoor Shaikh Attempts to improve population health typically rely on four categories for assessing risk. A fifth needs to be added.
Language and Mental Health By Donna Hardaker Sally Spencer-Thomas Terms like "successful suicide" are common, but they create the wrong climate for addressing mental health.
Do Healthcare Costs Shift to Work Comp? By Ramona Tanabe Yes. Higher reimbursement rates for treatment under workers' comp encourage doctors to classify injuries as work-related.
Are Your Health Cost Savings an Illusion? By Tom Emerick David Toomey “Physicians overestimate the benefits of everything from interventions for back pain to cancer chemotherapy.”
How to Push Back on Healthcare Premiums By Andy Neary Many employers get talked into just comparing this year's premiums against last year's. Tougher questions need to be asked.
8 Start-ups Aiming to Revive Life Insurance By Amy Radin The life insurance industry is suffering from a dying (literally) distribution model, complex products and a flawed purchase funnel, but....
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.